Abstract
We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis. Clinical improvement was observed in all cases, without adverse events, although significant reduction of urinary viral load was observed 2 weeks after the end of cidofovir in 5 out of 6 patients who completed the treatment.
| Original language | English |
|---|---|
| Pages (from-to) | 55-57 |
| Number of pages | 3 |
| Journal | Pediatric Infectious Disease Journal |
| Volume | 28 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jan 2009 |
Fingerprint
Keywords
- BK virus
- cidofovir
- hemorrhagic cystitis
- probenecid
ASJC Scopus subject areas
- Pediatrics, Perinatology, and Child Health
- Infectious Diseases
- Microbiology (medical)
Cite this
Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant. / Faraci, Maura; Cuzzubbo, Daniela; Lanino, Edoardo; Di Marco, Eddi; Cirillo, Carmela; Dallorso, Sandro; Morreale, Giuseppe; Moroni, Cristina; Castagnola, Elio.
In: Pediatric Infectious Disease Journal, Vol. 28, No. 1, 01.2009, p. 55-57.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Low dosage cidofovir without probenecid as treatment for bk virus hamorrhagic cystitis after hemopoietic stem cell transplant
AU - Faraci, Maura
AU - Cuzzubbo, Daniela
AU - Lanino, Edoardo
AU - Di Marco, Eddi
AU - Cirillo, Carmela
AU - Dallorso, Sandro
AU - Morreale, Giuseppe
AU - Moroni, Cristina
AU - Castagnola, Elio
PY - 2009/1
Y1 - 2009/1
N2 - We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis. Clinical improvement was observed in all cases, without adverse events, although significant reduction of urinary viral load was observed 2 weeks after the end of cidofovir in 5 out of 6 patients who completed the treatment.
AB - We describe a single-center pediatric experience with 1 mg/kg/wk cidofovir without probenecid in 7 children with BK virus-associated hemorrhagic cystitis. Clinical improvement was observed in all cases, without adverse events, although significant reduction of urinary viral load was observed 2 weeks after the end of cidofovir in 5 out of 6 patients who completed the treatment.
KW - BK virus
KW - cidofovir
KW - hemorrhagic cystitis
KW - probenecid
UR - http://www.scopus.com/inward/record.url?scp=66149101543&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=66149101543&partnerID=8YFLogxK
U2 - 10.1097/INF.0b013e3181812cb9
DO - 10.1097/INF.0b013e3181812cb9
M3 - Article
C2 - 19057462
AN - SCOPUS:66149101543
VL - 28
SP - 55
EP - 57
JO - Pediatric Infectious Disease Journal
JF - Pediatric Infectious Disease Journal
SN - 0891-3668
IS - 1
ER -